Scarica l'app Stockscreener
14.12
2.54%
0.35
Dopo l'orario di chiusura:
13.70
-0.42
-2.97%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$13.77
Aprire:
$13.78
Volume 24 ore:
1.29M
Relative Volume:
1.01
Capitalizzazione di mercato:
$1.10B
Reddito:
$1.53B
Utile/perdita netta:
$40.23M
Rapporto P/E:
28.24
EPS:
0.5
Flusso di cassa netto:
$60.93M
1 W Prestazione:
+14.15%
1M Prestazione:
+12.15%
6M Prestazione:
-41.80%
1 anno Prestazione:
-34.84%
Intervallo 1D:
$13.71
$14.15
Intervallo di 1 settimana:
$12.38
$14.15
Portata 52W:
$11.06
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Nome
Integra Lifesciences Holdings Corp
Settore
Industria
Telefono
(609) 275-0500
Indirizzo
1100 CAMPUS ROAD, PRINCETON, NJ
Confronta IART con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
14.12 | 993.36M | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
129.40 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-31 | Aggiornamento | Argus | Hold → Buy |
| 2024-12-02 | Iniziato | Morgan Stanley | Underweight |
| 2024-10-07 | Aggiornamento | BTIG Research | Sell → Neutral |
| 2024-07-30 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-07-30 | Downgrade | Citigroup | Neutral → Sell |
| 2024-05-07 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-05-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-12-05 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | Iniziato | CL King | Buy |
| 2023-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-06-08 | Downgrade | Argus | Buy → Hold |
| 2023-05-24 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Downgrade | Citigroup | Neutral → Sell |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-25 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2021-12-17 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-09-15 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-05-27 | Iniziato | Citigroup | Neutral |
| 2020-04-03 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | Iniziato | SunTrust | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-08-07 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-07-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Neutral |
| 2018-01-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-05-02 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | Iniziato | UBS | Buy |
Mostra tutto
Integra Lifesciences Holdings Corp Borsa (IART) Ultime notizie
5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call - ca.finance.yahoo.com
Developing predictive dashboards with Integra LifeSciences Holdings Corporation dataCEO Change & Free Community Consensus Stock Picks - Newser
Integra LifeSciences Holdings Corporation’s volatility index tracking explained2025 Trading Recap & Daily Stock Trend Reports - Newser
IART Q2 2025 Deep Dive: Operational Transformation and Supply Recovery Shape Outlook - ca.finance.yahoo.com
Using data models to predict Integra LifeSciences Holdings Corporation stock movementFree Access to Real-Time Trade Insights - Newser
Technical analysis overview for Integra LifeSciences Holdings Corporation stock [Quarterly Growth Report]Free Weekly High Potential Stock Alerts - Newser
Why Integra LifeSciences Holdings Corporation stock attracts strong analyst attentionBuy Zone Strategy with Pattern Recognition - Newser
Price action breakdown for Integra LifeSciences Holdings CorporationShort-Term Upside Breakout Forecast System - Newser
Integra LifeSciences Holdings Corporation stock daily chart insightsConsistent Profit Signals with AI Models - Newser
Top chart patterns to watch in Integra LifeSciences Holdings CorporationBreakout Stock Opportunities with Low Drawdown - Newser
Is now a turning point for Integra LifeSciences Holdings CorporationFree Multi-Bagger Potential Stock Forecast Tools - Newser
Published on: 2025-08-10 02:52:05 - Newser
What’s the recovery path for long term holders of Integra LifeSciences Holdings CorporationShort-Term AI-Based Stock Price Forecast - Newser
What makes Integra LifeSciences Holdings Corporation stock price move sharplyBreakout Stock Opportunities with Low Drawdown - Newser
Technical analysis overview for Integra LifeSciences Holdings Corporation stockPortfolio Building Plan and Summary Guide - Newser
Evaluating Integra LifeSciences Holdings Corporation with trendline analysisTriple Digit Gain Opportunity Watchlist - newser.com
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q2 2025 Earnings Call Transcript - Insider Monkey
Has Integra LifeSciences Holdings Corporation Stock Ever Crashed Historical Volatility ReviewFree Intraday Trend Analysis for Fast Gains - Newser
Integra LifeSciences Holdings Corporation Company’s Quarterly Earnings Growth: What the Numbers SayFree Swing Trading Plan With Smart Signals - Newser
JMP reiterates Market Outperform rating on Integra LifeSciences stock By Investing.com - Investing.com Canada
JMP reiterates Market Outperform rating on Integra LifeSciences stock - Investing.com
KLP Kapitalforvaltning AS Cuts Stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
How Integra LifeSciences Holdings Corporation stock performs during market volatilityBuy and Hold Return Summary with Charts - Newser
Integra: Q2 Earnings Snapshot - Norwalk Hour
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations By Investing.com - Investing.com Canada
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations - Investing.com
Integra Lifesciences Holdings Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Integra LifeSciences Q2 2025 slides: Revenue dips, projects second-half rebound - Investing.com Canada
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Integra Lifesciences Holdings Corp Reports Q2 Revenue of $415.6M - GuruFocus
Integra LifeSciences (IART) Reports Strong Q2 Revenue Performanc - GuruFocus
Integra Lifesciences Holdings Corp Reports Q2 Revenue of $415.6M, Exceeding Estimates; Adjusted EPS at $0.45, Surpassing Expectations - GuruFocus
Integra LifeSciences (NASDAQ:IART) Beats Q2 Sales Targets - Yahoo Finance
Integra Lifesciences Topped Revenue Estimates Despite Investor Caution - Finimize
Integra LifeSciences Reports Second Quarter 2025 Financial Results - TradingView
Integra LifeSciences (IART) Reports Strong Q2 Revenue Performance - GuruFocus
Integra Lifesciences Holdings Corp to Report Q2 2025 Earnings on July 31, 2025 with Expected Revenue of $395.07 Million and Earnings of $0.00 per Share - AInvest
Earnings To Watch: Integra Lifesciences Holdings Corp (IART) Reports Q2 2025 Result - Yahoo Finance
Allianz Asset Management GmbH Buys 71,939 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Yiren Digital Releases 2024 ESG Report, Achieving 5% Greenhouse Gas Reduction and Preventing RMB 180 Million in Fraudulent Loans with AI Model. - AInvest
Integra LifeSciences (IART) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo.co
Published on: 2025-07-29 18:17:19 - metal.it
Cwm LLC Boosts Position in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Published on: 2025-07-28 21:45:23 - metal.it
Should I hold or sell Integra LifeSciences Holdings Corporation stock in 2025Discover breakthrough investment opportunities - Jammu Links News
What is Integra LifeSciences Holdings Corporation company’s growth strategyGet alerts on the hottest stocks daily - jammulinksnews.com
How Efficient Is Integra LifeSciences Holdings Corporation at Controlling Operating CostsFast Growing Stocks - Newser
Integra Lifesciences Holdings Corp Azioni (IART) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Integra Lifesciences Holdings Corp Azioni (IART) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '25 |
Option Exercise |
0.00 |
1,180 |
0 |
2,359 |
| Schwartz Eric | EVP, Chief Legal Officer & Sec |
Dec 03 '24 |
Sale |
24.59 |
4,070 |
100,102 |
59,511 |
0.31%
1.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):